Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.6036 USD
Market Closed
Updated:
May 17, 2024
Atara Biotherapeutics Inc
Other Current Assets
|
Atara Biotherapeutics Inc
Other Current Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other Current Assets
$8.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Assets
$4.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Assets
$2.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Assets
$623.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
35%
|
CAGR 10-Years
39%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Assets
$414.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
See Also
What is Atara Biotherapeutics Inc's Other Current Assets?
Other Current Assets
8.3m
USD
8.3m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Other Current Assets amounts to 8.3m USD.
What is Atara Biotherapeutics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-9%
-9%
Over the last year, the Other Current Assets growth was -36%. The average annual Other Current Assets growth rates for Atara Biotherapeutics Inc have been -25% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
